DAMORA THERAPEUTICS, INC. (DMRA) Operating cash flow 2019–2025
DAMORA THERAPEUTICS, INC. (DMRA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.7MFY2025 · since FY2019: -$19.3M → -$6.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.7M | +63.9% |
| FY2024 | -$18.6M | +49.5% |
| FY2023 | -$36.9M | +14.0% |
| FY2022 | -$42.9M | +17.9% |
| FY2021 | -$52.3M | -36.9% |
| FY2020 | -$38.2M | -97.7% |
| FY2019 | -$19.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice